# Poor Response to Monoclonal Therapy in Asthma

> **NCT04114396** · — · UNKNOWN · sponsor: **University of Nottingham** · enrollment: 50 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Anti-IL5 Antibody
- **PROCEDURE:** Bronchoscopy

## Key facts

- **NCT ID:** NCT04114396
- **Lead sponsor:** University of Nottingham
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-31
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-07-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04114396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04114396, "Poor Response to Monoclonal Therapy in Asthma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04114396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*